Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults
Authors not listed
University Hospital, Toulouse · 2017
Abstract
The current study seeks to examine the prevalence of amyloid pathology, among patients referred to the Toulouse Geriatric Frailty Clinic presenting objective memory impairment. We also aim to fully characterize the clinical progression of frail cognitively impaired patients presenting AD (Alzheimer Disease) pathology vs those who also present a cognitive impairment but do not have AD pathology.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2017). Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults. <em>University Hospital, Toulouse</em>. https://clinicaltrials.gov/study/NCT03129269
Vancouver
Anonymous. Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults. University Hospital, Toulouse. 2017.
BibTeX
@misc{anon2017Cognit,
title = {Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults},
author = {Anonymous},
journal = {University Hospital, Toulouse},
year = {2017},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.